Get the Stockscreener App
3.4388
1.74%
0.0588
Shuttle Pharmaceuticals Holdings Inc stock is traded at $3.4388, with a volume of 28,258.
It is up +1.74% in the last 24 hours and down -11.37% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$3.38
Open:
$3.2504
24h Volume:
28,258
Relative Volume:
0.22
Market Cap:
$3.68M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-7.4757
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
+3.58%
1M Performance:
-11.37%
6M Performance:
-77.71%
1Y Performance:
-93.57%
1-Day Range:
$3.2504
$3.45
1-Week Range:
$3.09
$3.49
52-Week Range:
$3.00
$82.50
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
3.4388 | 3.51M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations - MSN
Live market analysis of Shuttle Pharmaceuticals Holdings Inc.Earnings Trend Report & Weekly Breakout Watchlists - Newser
Chart based analysis of Shuttle Pharmaceuticals Holdings Inc. trends2025 Bull vs Bear & Short-Term Trading Alerts - Newser
Chart overlay techniques for tracking Shuttle Pharmaceuticals Holdings Inc.Weekly Gains Summary & Stepwise Trade Signal Implementation - Newser
Shuttle Pharmaceuticals Holdings Inc. stock trendline breakdownJuly 2025 Fed Impact & Community Consensus Picks - Newser
How to track smart money flows in Shuttle Pharmaceuticals Holdings Inc.Sell Signal & Smart Allocation Stock Tips - Newser
Is Shuttle Pharmaceuticals Holdings Inc. stock poised for growthJuly 2025 Patterns & Reliable Volume Spike Alerts - Newser
Is Shuttle Pharmaceuticals Holdings Inc. stock reversal real or fakeEarnings Growth Summary & Free Verified High Yield Trade Plans - Newser
What recovery options are there for Shuttle Pharmaceuticals Holdings Inc.Earnings Overview Summary & AI Driven Price Predictions - Newser
Tools to monitor Shuttle Pharmaceuticals Holdings Inc. recovery probabilityPortfolio Value Report & Low Drawdown Momentum Ideas - Newser
How to build a dashboard for Shuttle Pharmaceuticals Holdings Inc. stockAnalyst Downgrade & Community Consensus Stock Picks - Newser
Published on: 2025-08-18 23:04:36 - Newser
What momentum shifts mean for Shuttle Pharmaceuticals Holdings Inc.Quarterly Portfolio Report & Breakout Confirmation Trade Signals - Newser
Does Shuttle Pharmaceuticals Holdings Inc. qualify in momentum factor screening2025 Buyback Activity & Expert Verified Stock Movement Alerts - Newser
Using Ichimoku Cloud for Shuttle Pharmaceuticals Holdings Inc. technicalsMarket Growth Summary & Free High Return Stock Watch Alerts - Newser
Can volume confirm reversal in Shuttle Pharmaceuticals Holdings Inc.Analyst Downgrade & Free Long-Term Investment Growth Plans - Newser
Published on: 2025-08-17 18:15:27 - Newser
Using data tools to time your Shuttle Pharmaceuticals Holdings Inc. exitJuly 2025 Weekly Recap & Weekly Momentum Picks - Newser
Backtesting results for Shuttle Pharmaceuticals Holdings Inc. trading strategiesWeekly Profit Report & AI Powered Buy/Sell Recommendations - Newser
Should you wait for a breakout in Shuttle Pharmaceuticals Holdings Inc.2025 Dividend Review & Free Community Consensus Stock Picks - Newser
Can you recover from losses in Shuttle Pharmaceuticals Holdings Inc.July 2025 Drop Watch & AI Optimized Trading Strategy Guides - Newser
Applying Elliott Wave Theory to Shuttle Pharmaceuticals Holdings Inc.2025 EndofYear Setup & Free High Return Stock Watch Alerts - Newser
Relative strength of Shuttle Pharmaceuticals Holdings Inc. in sector analysisJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - Newser
Smart tools for monitoring Shuttle Pharmaceuticals Holdings Inc.’s price actionEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
Published on: 2025-08-16 21:11:36 - Newser
What data driven models say about Shuttle Pharmaceuticals Holdings Inc.’s future - Newser
What analysts say about Shuttle Pharmaceuticals Holdings Inc. stock outlook2025 Dividend Review & Weekly Top Performers Watchlists - Newser
Will Syndax Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsEarnings Risk Summary & Reliable Price Breakout Signals - Newser
Regression analysis insights on Shuttle Pharmaceuticals Holdings Inc. performanceWeekly Loss Report & Free Low Drawdown Momentum Trade Ideas - Newser
Shuttle Pharma Announces Q2 2025 Update: Phase 2 Trial Progress, Financial Strength, and Leadership Enhancements - AInvest
Shuttle Pharma Provides Second Quarter 2025 Corporate Update - GlobeNewswire
Shuttle Pharma's Glioblastoma Treatment Shows Promise as Phase 2 Trial Advances with Strong Patient Tolerance - Stock Titan
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):